Ecofibre is a pioneering company that operates at the intersection of sustainable technology and health innovation, with a focused strategy across multiple hemp-related business lines. The company has built a comprehensive portfolio of vertically integrated businesses spanning hemp seed genetics, natural health care products, advanced manufacturing technologies, and pharmaceutical research. With over 20 years of industry experience, Ecofibre has positioned itself as a global leader in hemp technologies, leveraging an extensive genetic library of over 300 cannabis landraces from more than 25 countries.
The company’s business segments include Ecofibre Genetics, which specializes in plant breeding and varietal development; Ananda Health, a manufacturer of plant-based wellness products for humans and pets; Ecofibre Advanced Technologies, an advanced manufacturing business focused on sustainable materials and polymer compounding; and EOF Bio Inc., a clinical-stage biotechnology company developing cannabinoid-based drugs with an initial focus on women’s health and endometriosis. Each division represents a strategic approach to utilizing hemp and cannabis technologies across health, materials, and pharmaceutical domains.
Ecofibre is deeply committed to sustainability and supply chain innovation, working diligently to improve manufacturing and growing practices while developing robust supply chains in the United States and Australia. The company’s vision extends beyond commercial success, aiming to provide innovative solutions that address emerging health challenges and resource sustainability issues. By integrating advanced research, technological capabilities, and a holistic approach to hemp-based technologies, Ecofibre is positioning itself as a transformative force in multiple industries, from wellness and healthcare to advanced materials and pharmaceutical research.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
